A Prospective, Randomized, Bi-center Study to Compare the Outcome of Adjuvant Radiotherapy With Concomitant or Sequential Arimidex in Postmenopausal Women With Breast Cancer

Trial Profile

A Prospective, Randomized, Bi-center Study to Compare the Outcome of Adjuvant Radiotherapy With Concomitant or Sequential Arimidex in Postmenopausal Women With Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Breast cancer
  • Focus Pharmacodynamics; Registrational
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Jun 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2013 to 1 Jul 2015.
    • 21 May 2014 Status changed from recruiting to active, no longer recruiting, according to abstract presented at American Society of Clinical Oncology Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top